ILDSTAD SUZANNE (Chief Scientific Officer) sold 4.9% of their position (148.98K shares) of TOURMALINE BIO, INC. on the open market
Open‑market sale worth $319.3K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 4/19/2023ACC: 0001209191-23-024771
DirectorOfficer10% Owner· Chief Scientific Officer
Since May 2021
-148.98K
Net shares
Net seller
$319.3K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
148.98K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−99.77K
Price / share
$2.14
Trade value
$213.53K
% of position
3.3%
4/17/2023
3.05M→2.95M
Common Stock
Direct
Shares
−49.21K
Price / share
$2.15
Trade value
$105.80K
% of position
1.7%
4/18/2023
2.95M→2.91M
Total
Net shares
−148.98K
Net value
-$319.33K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/17/2023 | S · Sale | −99.77K | $2.14 | $213.53K | 3.3% | 3.05M | 2.95M |
| Common Stock Direct | 4/18/2023 | S · Sale | −49.21K | $2.15 | $105.80K | 1.7% | 2.95M | 2.91M |
| Total | −148.98K | -$319.33K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)3
Common Stock
IndirectShares owned654.21K
Common Stock
IndirectShares owned1.20M
Common Stock
IndirectShares owned654.21K
Total
2.51M indirect2.51M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 654.21K | Indirect |
| Common Stock | 1.20M | Indirect |
| Common Stock | 654.21K | Indirect |
| Total | 2.51M | 2.51M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported